The Strathclyde Institute of Pharmacy & Biomedical Sciences is a major research centre in Scotland and is amongst the UK's top Schools of Pharmacy. We have a wide range of state-of-the-art research facilities and recently benefited from the opening of a new £36m building.
Cellular Basis of Disease
Research Group Lead: Professor Luke Chamberlain
The Cellular Basis of Disease research group investigates molecular and cellular processes that link to a range of important disorders. The group employ a wide array of cutting-edge techniques, working at the molecular, cellular and systems level and using a range of disease models. Research themes of the group focus on cardiovascular and metabolic disease, neurological disorders and mental health, cancer and inflammation.
The group has a weekly seminar programme that features both external speakers, and students and post-doctoral scientists affiliated to the group. The group encourage enquiries from prospective research fellows and PhD students. The research profile of group members can be viewed via the links below.
- Cancer and inflammatory disease
Sub-group lead: Professor Susan Pyne - Cardiovasular and metabolic disease
Sub-group leads: Drs Susan Currie & Margaret Cunningham - Neuroscience and mental health
Sub-group lead: Dr Trevor Bushell
Pharmaceutical Sciences
Through the discovery, development and manufacture of innovative drugs millions of people’s lives are saved and the quality of life for many others are improved. The Pharmaceutical Sciences research at the Strathclyde Institute of Pharmacy and Biomedical Sciences contributes to this by uniting internationally-leading researchers in the development, manufacture and testing of the next generation of medicines that promote the effective delivery and targeting of drugs.
- Drug Discovery, Formulation and Delivery
Sub-group lead: Dr. Philipp Seib - Materials & Manufacture
Sub-group lead: Professor Joop Ter Horst
Microbiology and industrial biotechnology
Research Group lead: Professor Paul A Hoskisson
Microorganisms are the most abundant and diverse organisms on earth and are key members of every niche on the planet. Our research encompasses a broad spectrum of work from the fundamental science of model microorganisms, studying host-pathogen interactions, combatting antimicrobial resistance and discovery of new drug molecules through to the exploitation of microorganisms for biotechnology and in industry.
Pharmacoepidemiology & Health Care
Research Group lead: Dr Amanj Kurdi
Pharmacoepidemiology is the study of the use and effects of drugs in large populations, covering both the benefits and the risks for the patients involved.
Health Care research focuses on optimising health outcomes and reducing resource wastage through the design and testing of new health care intervention models.
Our research is focused on person-centred, safe and effective use of medicines and public health improvement, with individual researchers active across both pharmacoepidemiology and health care.
